Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06384196 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Identity-Based Transdiagnostic Therapy for Young People With Anxiety and Depression

Study acronym: IBTTYOUNG
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Jun 30, 2026 → Jun 30, 2027
See other at-risk trials from University of Barcelona

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Jun 30, 2026 to Jun 30, 2027 Show 6 more changesShow less
    • Study completion pushed from Nov 2, 2026 to Nov 2, 2027
    • Secondary endpoints: details revised at 8 of 9 entries
    • Study description expanded, about 6 words
    • Collaborators revised (3)
    • Publications: details revised at 12 of 14 entries
    • Eligibility criteria expanded, about 5 words
  2. Minor Collaborators: 2 to 3v8
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Jun 30, 2025 to Jun 30, 2026
    • Study completion date: Nov 2, 2025 to Nov 2, 2026
    • Site details revised at 2 of 2 sites
    v7
  4. Notable Start date: Jan 2, 2025 to May 2, 2025v6
  5. Notable Start date: Oct 2, 2024 to Jan 2, 2025
    • Study description revised
    • Publications: 15 to 14
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Notable Start date: Jul 2, 2024 to Oct 2, 2024
    • Secondary endpoints: 10 to 9
    v4
  2. Minor Study description shortened, about 30 wordsv3
  3. Minor Eligibility criteria shortened, about 59 words
    • Secondary endpoints revised (10)
    • Study description expanded, about 24 words
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
3,263 trials monitored
See 159 trials at risk
3,055 trials monitored
See 173 trials at risk
Depression and anxiety are the most prevalent mental disorders among both the general population and young adults, and transdiagnostic treatments for these patients are mostly based on cognitive-behavioral therapy (CBT). Based on common (transdiagnostic) principles of treatment (e.g., emotional exposure), these approaches have proliferated and demonstrated their efficacy in comparison to disorder-specific treatments. Although there are a few transdiagnostic approaches for children and adolescents, it was not possible to not find anyone targeting young people. For this reason, the investigators proposed the Identity-Based Transdiagnostic Therapy (IBTT) as a new treatment modality ideally created to address the challenge of improving the outcomes of psychotherapy for young adults with anxiety and/or depression. The IBTT is a psychological treatment for emotional disorders specifically designed for the youths in terms of their attitudes to treatment (attractiveness, engagement), and highly personalized to their construal of self and others. This project will allow testing the hypothesis that a novel brief psychotherapeutic intervention, IBTT, will be more efficacious in the treatment of the anxiety and/or depression of young adults than the well-established CBT-based Unified Protocol.
Trial Details
NCT Number NCT06384196
Lead Sponsor University of Barcelona
Collaborators: Badalona Serveis Assistencials, Nou Barris Mental Health Center, Pere Claver Grup
Conditions
(from sponsor)
Depression, Anxiety
Related terms Anxiety Disorders, Depression, Patient Satisfaction, Personal Satisfaction, Psychological Well-Being
Enrollment 138 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov